Auddia (AUUD) 10-Q 14 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 13, 2023
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-40071
Entity Registrant Name	AUDDIA INC.
Entity Central Index Key	0001554818
Entity Tax Identification Number	45-4257218
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2100 Central Ave.
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Boulder
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80301
City Area Code	(303)
Local Phone Number	219-9771
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		19,947,223
Common Stock, par value $0.001 per share
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	AUUD
Security Exchange Name	NASDAQ
Warrants, each exercisable for one share of Common Stock
Title of 12(b) Security	Warrants, each exercisable for one share of Common Stock
Trading Symbol	AUUDW
Security Exchange Name	NASDAQ

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 2,199,678	$ 1,661,434
Accounts receivable, net	574	137
Prepaid insurance	56,704	0
Total current assets	2,256,956	1,661,571
Non-current assets:
Property and equipment, net of accumulated depreciation	22,084	41,080
Software development costs, net of accumulated amortization	3,545,610	4,134,225
Deferred offering costs	170,259	222,896
Prepaids and other non-current assets	47,364	51,754
Total non-current assets	3,785,317	4,449,955
Total assets	6,042,273	6,111,526
Current liabilities:
Accounts payable and accrued liabilities	587,641	324,138
Notes payable to related party, net of debt issuance costs	2,993,639	1,775,956
Stock awards liability	45,981	161,349
Total current liabilities	3,627,261	2,261,443
Total liabilities	3,627,261	2,261,443
Commitments and contingencies (Note 5)
Shareholders' equity:
Preferred stock - $0.001 par value, 10,000,000 authorized and 0 shares issued and outstanding	0	0
Common stock - $0.001 par value, 100,000,000 authorized and 19,947,223 and 12,654,949 shares issued and outstanding September 30, 2023 and December 31, 2022	19,947	12,654
Additional paid-in capital	80,725,555	75,573,263
Accumulated deficit	(78,330,490)	(71,735,834)
Total shareholders' equity	2,415,012	3,850,083
Total liabilities and shareholders' equity	$ 6,042,273	$ 6,111,526

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	19,947,223	12,654,949
Common stock, shares outstanding	19,947,223	12,654,949

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Direct cost of services	43,470	32,712	130,809	128,806
Sales and marketing	316,297	298,924	765,176	1,396,010
Research and development	227,133	181,596	617,622	481,611
General and administrative	777,496	540,220	2,596,831	2,400,503
Depreciation and amortization	465,166	274,839	1,350,820	721,971
Total operating expenses	1,829,562	1,328,291	5,461,258	5,128,901
Loss from operations	(1,829,562)	(1,328,291)	(5,461,258)	(5,128,901)
Other (expense) income:
Interest expense	(286,920)	(2,023)	(1,133,398)	(5,058)
Total other expense	(286,920)	(2,023)	(1,133,398)	(5,058)
Loss before income taxes	(2,116,482)	(1,330,314)	(6,594,656)	(5,133,959)
Provision for income taxes	0	0	0	0
Net loss	$ (2,116,482)	$ (1,330,314)	$ (6,594,656)	$ (5,133,959)

Condensed Statements of Opera_2

Condensed Statements of Operations (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net loss per share attributable to common stockholders, basic	$ (0.11)	$ (0.11)	$ (0.41)	$ (0.41)
Net loss per share attributable to common stockholders, diluted	$ (0.11)	$ (0.11)	$ (0.41)	$ (0.41)
Weighted average common shares outstanding, basic	19,947,223	12,514,763	16,043,086	12,498,206
Weighted average common shares outstanding, diluted	19,947,223	12,514,763	16,043,086	12,498,206

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 12,416	$ 74,236,910	$ (64,838,389)	$ 9,410,937
Beginning balance, shares at Dec. 31, 2021	12,416,408
Exercise of Restricted Stock Units	$ 98	(98)
Exercise of Restricted Stock Units, shares	98,355
Share-based compensation		385,908		385,908
Reclassification of share-based compensation liability		(128,534)		(128,534)
Net loss			(1,753,258)	(1,753,258)
Ending balance, value at Mar. 31, 2022	$ 12,514	74,494,186	(66,591,647)	7,915,053
Ending balance, shares at Mar. 31, 2022	12,514,763
Beginning balance, value at Dec. 31, 2021	$ 12,416	74,236,910	(64,838,389)	9,410,937
Beginning balance, shares at Dec. 31, 2021	12,416,408
Net loss				(5,133,959)
Ending balance, value at Sep. 30, 2022	$ 12,514	74,727,187	(69,972,348)	4,767,353
Ending balance, shares at Sep. 30, 2022	12,514,763
Beginning balance, value at Mar. 31, 2022	$ 12,514	74,494,186	(66,591,647)	7,915,053
Beginning balance, shares at Mar. 31, 2022	12,514,763
Share-based compensation		285,921		285,921
Reclassification of share-based compensation liability		(7,262)		(7,262)
Net loss			(2,050,385)	(2,050,385)
Ending balance, value at Jun. 30, 2022	$ 12,514	74,772,845	(68,642,032)	6,143,327
Ending balance, shares at Jun. 30, 2022	12,514,763
Share-based compensation		26,657		26,657
Revaluation of share-based compensation liability		(72,315)		(72,315)
Net loss			(1,330,314)	(1,330,314)
Ending balance, value at Sep. 30, 2022	$ 12,514	74,727,187	(69,972,348)	4,767,353
Ending balance, shares at Sep. 30, 2022	12,514,763
Beginning balance, value at Dec. 31, 2022	$ 12,654	75,573,262	(71,735,834)	3,850,083
Beginning balance, shares at Dec. 31, 2022	12,654,949
Exercise of Restricted Stock Units	$ 196	42,601		42,797
Exercise of Restricted Stock Units, shares	195,760
Share-based compensation		357,680		357,680
Net loss			(2,155,312)	(2,155,312)
Ending balance, value at Mar. 31, 2023	$ 12,850	75,973,543	(73,891,146)	2,095,247
Ending balance, shares at Mar. 31, 2023	12,850,709
Beginning balance, value at Dec. 31, 2022	$ 12,654	75,573,262	(71,735,834)	3,850,083
Beginning balance, shares at Dec. 31, 2022	12,654,949
Net loss				(6,594,656)
Ending balance, value at Sep. 30, 2023	$ 19,947	80,725,555	(78,330,490)	2,415,012
Ending balance, shares at Sep. 30, 2023	19,947,223
Beginning balance, value at Mar. 31, 2023	$ 12,850	75,973,543	(73,891,146)	2,095,247
Beginning balance, shares at Mar. 31, 2023	12,850,709
Issuance of common shares, net of costs	$ 7,097	3,956,787		3,963,884
Issuance of common shares, net of costs, shares	7,096,514
Exercise of Restricted Stock Units		(42,797)		(42,797)
Issuance of warrants		383,004		383,004
Share-based compensation		224,856		224,856
Revaluation of share-based compensation liability		30,445		30,445
Net loss			(2,322,862)	(2,322,862)
Ending balance, value at Jun. 30, 2023	$ 19,947	80,525,838	(76,214,008)	4,331,777
Ending balance, shares at Jun. 30, 2023	19,947,223
Share-based compensation		217,141		217,141
Revaluation of share-based compensation liability		(17,424)		(17,424)
Net loss			(2,116,482)	(2,116,482)
Ending balance, value at Sep. 30, 2023	$ 19,947	$ 80,725,555	$ (78,330,490)	$ 2,415,012
Ending balance, shares at Sep. 30, 2023	19,947,223

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (6,594,656)	$ (5,133,959)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Finance charge associated with debt issuance cost	850,688	0
Depreciation and amortization	1,350,820	721,971
Share-based compensation expense	799,677	698,486
Change in assets and liabilities:
Accounts receivable	(437)	52
Prepaid insurance	(56,705)	0
Prepaids and other non-current assets	4,390	(1,065)
Accounts payable and accrued liabilities	241,269	92,403
Net cash used in operating activities	(3,404,954)	(3,622,112)
Cash flows from investing activities:
Software capitalization	(743,208)	(1,673,517)
Purchase of property and equipment	0	(3,809)
Net cash used in investing activities	(743,208)	(1,677,326)
Cash flows from financing activities:
Net settlement of share-based compensation liability	(80,115)	(88,723)
Proceeds from related party debt	750,000	0
Proceeds from issuance of common shares	4,016,521	0
Net cash provided by (used in) financing activities	4,686,406	(88,723)
Net increase in cash	538,244	(5,388,161)
Cash, beginning of year	1,661,434	6,345,291
Cash and restricted cash, end of period	2,199,678	957,130
Supplemental disclosures of cash flow information:
Cash paid for Interest	6,000	5,058
Supplemental disclosures of non-cash activity:
Reclassification of deferred offering cost	52,637	0
Original issue discount and issuance of warrants on related party debt	$ 458,004	$ 0

Description of Business, Basis

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Description of Business, Basis of Presentation and Summary of Significant Accounting Policies	Note 1 - Description of Business, Basis of Presentation and Summary of Significant Accounting Policies Description of Business Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado. Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). Interim Financial Information The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2022 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The condensed financial statements include some amounts that are based on management's best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company's common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant. Risks and Uncertainties The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks. Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period to comply with certain new or revised accounting standards that have different effective dates for public and private companies. Going Concern The Company had cash of $ 2,199,678 As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management has plans to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, such as the White Lion equity line of credit (refer to Note 8) and additional future financing agreements. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s current level of cash is not sufficient to execute the business plan. For the foreseeable future, the Company will incur significant operating expenses, capital expenditures and working capital funding that will deplete cash on hand by February 2024. Cash The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had no The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of September 30, 2023, the Company had approximately $ 1.9 million 1.4 million Software Development Costs The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. We determined that no such impairments were required during the three months and nine months ended September 30, 2023. Software development costs of $ 213,705 394,893 743,208 1,673,517 458,973 262,703 1,331,823 693,441 Revenue Recognition Revenue will be measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and will be recognized based on consideration specified in a contract with a customer, and excludes any sales incentives and amounts collected on behalf of third parties. The Company will recognize revenue when a performance obligation is satisfied by transferring control over a service or product to a customer. The Company will report revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the condensed statements of operations. Collected taxes will be recorded within Other current liabilities until remitted to the relevant taxing authority. Subscriber revenue will consist primarily of subscription fees and other ancillary subscription-based revenues. Revenue will be recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions. Customers may pay for the services in advance of the performance obligation and therefore these prepayments would be recorded as deferred revenue. The deferred revenue will be recognized as revenue in the statement of operations as the services are provided. Share-Based Compensation The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant in accordance with ASC 718. Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods. Certain share-based compensation awards include a net-share settlement feature that provides the grantee an option to withhold shares to satisfy tax withholding requirements and are classified as a share-based compensation liability. Cash paid to satisfy tax withholdings is classified as financing activities in the condensed statements of cash flows. Recently Adopted ASUs ASU 2016-13-Financial Instruments-Credit Losses-

Property & Equipment and Softwa

Property & Equipment and Software Development Costs	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Property & Equipment and Software Development Costs	Note 2 – Property & Equipment and Software Development Costs Property and equipment and software development costs consisted of the following as of: Schedule of property, equipment and software development costs September 30, 2023 December 31, 2022 Computers and equipment $ 99,939 $ 99,939 Furniture 7,263 7,262 Accumulated depreciation (85,118 ) (66,121 ) Total property and equipment, net $ 22,084 $ 41,080 Software development costs $ 7,369,257 $ 6,626,049 Accumulated amortization (3,823,647 ) (2,491,824 ) Total software development costs, net $ 3,545,610 $ 4,134,225 The Company recognized depreciation expense of $ 6,193 12,136 458,973 262,703 18,997 28,529 1,331,823 693,441

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Note 3 – Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consist of the following: Schedule of accounts payable and accrued liabilities September 30, 2023 December 31, 2022 Accounts payable and accrued liabilities $ 269,159 $ 289,955 Credit cards payable 14,517 6,072 Accrued interest 303,965 28,111 Total accounts payable and accrued liabilities $ 587,641 $ 324,138

Notes Payable to Related Party,

Notes Payable to Related Party, net of debt issuance costs	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Notes Payable to Related Party, net of debt issuance costs	Note 4 – Notes Payable to Related Party, net of debt issuance costs In November 2022, the Company entered into a Secured Bridge Note (the “Prior Note”) financing with an existing shareholder of the Company. The principal amount of the Prior Note was $ 2,200,000 200,000 300,000 361,878 300,000 94,083 In connection with an additional financing with the same related party during April of 2023, the Company cancelled the original 300,000 600,000 35,981 300,000 300,000 During May of 2023, the Company extended the maturity date of the Prior Notes by six months to November 2023 at an increased annual interest rate of 20%. In connection with this extension, the 300,000 As of September 30, 2023, and December 31, 2022, the balance of the Prior Note, net of debt issuance costs, was $2,168,639 and $1,775,956, respectively. Interest expense related to the Prior Note for the three and nine months ended September 30, 2023, was $157,298 and $762,112. As noted above, the Company entered into an additional Secured Bridge Note (“New Note”) financing with the same accredited investor and significant existing shareholder during April of 2023. In addition, the Company also amended the terms of the Prior Note. The principal amount of the New Note is $ 825,000 75,000 325,000 325,000 252,940 As of September 30, 2023, the balance of the New Note issued in April 2023, net of debt issuance costs, was $ 825,000 401,441 On July 31, 2023, the Company extended the maturity date of the New Note to November 30, 2023. In connection with such extension, 325,000 outstanding unvested warrants became vested and exercisable.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 5 – Commitments and Contingencies Operating Lease In April 2021, the Company entered into a lease agreement for office space in Boulder, Colorado comprising 8,639 square feet. The lease commenced on May 15, 2021, and terminated after 12 months. The Company subsequently extended the lease through November 2022. In November 2022, the Company amended the lease, reducing the square footage rented to 2,160 with a base rent of $4,018 per month. The amended lease terminates after 13 months. Rent expense, as part of general and administrative expenses as included in the Condensed Statement of Operations, was $ 12,053 39,935 49,491 83,117 Litigation In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company. There are no active litigations as of the date the financial statements were issued. However, a pre-IPO investor has contacted the Company claiming damages caused by alleged acts and omissions arising from a private financing by the Company. No complaint has been filed by the investor. The alleged damages asserted by the investor are less than approximately $300,000. The outcome of the complaint was neither probable or estimable as of the date the financial statements were issued. NASDAQ Deficiencies On May 23, 2023, we received a letter (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC (“Nasdaq”) indicating that, based upon the Company’s reported stockholder’s equity of $ 2,095,247 On July 10, 2023, the Company received a letter from Nasdaq advising that the Company had been granted an extension to file a Form 10-Q for the quarter-ended June 30, 2023 evidencing compliance with Stockholder’s Equity Requirement. The stockholder’s equity balance as of June 30, 2023 was $ 4,331,777 August 25, 2023, Nasdaq confirmed that the Company had regained compliance with the Stockholders’ Equity Requirement and that this matter is now closed. Separately, on April 24, 2023 we received a letter from Nasdaq indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the “Bid Price Requirement”). The letter indicated that the Company will be provided 180 calendar days (or until October 23, 2023) in which to regain compliance. If at any time during this 180 calendar day period the bid price of the Company’s common stock closes at or above $1.00 per share for a minimum of ten consecutive business days, Nasdaq will provide the Company with a written confirmation of compliance and the matter will be closed. On October 24, 2023, the Company received a written notice from the Nasdaq staff indicating that the Company had not regained compliance with the Bid Price Requirement and was not eligible for an additional 180 calendar day compliance period. As a result, the staff determined to delist the Company’s Common Stock from Nasdaq, unless the Company timely requests an appeal of the Staff’s determination to a Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. The Company has requested a hearing before the Panel to appeal the October notice and to address compliance with the Bid Price Requirement. While the appeal process is pending, the suspension of trading of the Company’s common stock, will be stayed and the Common Stock will continue to trade on Nasdaq until the hearing process concludes and the Panel issues a written decision. The hearing is expected to occur in mid-January 2024. The Company intends to consider all options to regain and maintain compliance with all Nasdaq continued listing requirements. The Company’s receipt of these Nasdaq letters does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.

Share-based Issuances

Share-based Issuances	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Share-based Issuances	Note 6 - Share-based Issuances Stock Options The following table presents the activity for stock options outstanding: Schedule of stock option activity Options Weighted Average Exercise Price Outstanding - December 31, 2022 1,663,173 $ 2.45 Granted 200,200 0.94 Forfeited/canceled (206,454 ) 1.51 Exercised – – Outstanding - September 30, 2023 1,656,919 $ 2.38 The following table presents the composition of options outstanding and exercisable: Schedule of options outstanding and exercisable Options Outstanding Options Exercisable Exercise Prices Number Price Life* Number Price* $2.70 22,264 $ 2.70 0.75 22,264 $ 2.70 $2.90 53,128 $ 2.90 4.11 53,128 $ 2.90 $4.26 171,197 $ 4.26 5.73 171,197 $ 4.26 $2.79 772,194 $ 2.79 7.23 553,122 $ 2.79 $1.79 198,750 $ 1.79 7.87 68,437 $ 1.79 $1.21 389,386 $ 1.21 8.95 292,039 $ 1.21 $0.40 50,000 $ 0.40 9.69 – $ 0.40 Total - September 30, 2023 1,656,919 $ 2.38 1,160,187 $ 2.59 * Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively. During the nine months ended September 30, 2023, the Company granted 200,200 Restricted Stock Units The following table presents the activity for restricted stock units outstanding: Schedule of restricted stock units outstanding Restricted Stock Units Weighted Average Grant Date Fair Value Outstanding - December 31, 2022 563,859 $ 2.14 Granted 37,500 1.24 Forfeited/canceled (118,350 ) 1.83 Vested/issued (195,759 ) 1.83 Outstanding - September 30, 2023 287,250 $ 2.37 During the nine months ended September 30, 2023, the Company granted 37,500 In 2023, certain restricted stock unit holders elected a net-share settlement for vested shares to satisfy income tax requirements. The Company applied modification accounting in accordance with ASC 718 and recorded the expected value of these share-based awards as a liability. The Company recognized a share-based compensation liability as of September 30, 2023, of $ 45,981 The Company recognized share-based compensation expense related to stock options and restricted stock units of $ 799,677 698,486 1,447,278 Warrants The following table presents the activity for warrants outstanding: Schedule of warrant outstanding Warrants Weighted Average Exercise Price Outstanding - December 31, 2022 4,472,099 $ 4.62 Granted 950,000 0.61 Forfeited/canceled – – Exercised – – Outstanding - September 30, 2023 5,422,099 $ 3.84 5,422,099 2.69

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2023
Net loss per share attributable to common stockholders
Net Loss Per Share	Note 7 – Net Loss Per Share Basic net loss per share is computed by dividing net loss, which is allocated based upon the proportionate amount of weighted average shares outstanding, to each class of shareholder’s stock outstanding during the period. For the calculation of diluted net loss per share, net loss per share attributable to common shareholders for basic net loss per share is adjusted by the effect of dilutive securities, including awards under our equity compensation plans. As of September 30, 2023, and 2022, 7,079,016 6,271,219

Equity Financings

Equity Financings	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Equity Financings	Note 8 – Equity Financings Equity Line Sales of Common Stock On November 14, 2022, the Company entered into a Common Stock Purchase Agreement (the “White Lion Purchase Agreement”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”) for an equity line facility. In April and June 2023, the Company closed on three sales of Common Stock under the White Lion Purchase Agreement. As a result, the Company issued an aggregate of 2,361,514 1.3 million Any proceeds that the Company receives under the White Lion Purchase Agreement are expected to be used for working capital and general corporate purposes. The aggregate number of shares of common stock that the Company can sell to White Lion under the White Lion Purchase Agreement (including the Commitment Shares) may in no case exceed 2,501,700 The Company recognized all offering costs related to the equity line of credit as deferred offering costs in accordance with the guidance in ASC 835-30-S45. Sale of Common Shares (S-3 offering) In June 2023, the Company sold 4,735,000 2.7 million

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 9 – Subsequent Events Replacement Equity Line with White Lion On November 6, 2023, the Company entered into a new Common Stock Purchase Agreement and a related registration rights agreement with White Lion. Pursuant to the new Common Stock Purchase Agreement, the Company has the right, but not the obligation to require White Lion to purchase, from time to time until December 31, 2024, up to $10,000,000 in aggregate gross purchase price of newly issued shares of the Company’s common stock, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. In connection with the new Common Stock Purchase Agreement, the parties agreed to terminate the previous Common Stock Purchase Agreement with White Lion.

Description of Business, Basi_2

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Description of Business	Description of Business Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado.
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).
Interim Financial Information	Interim Financial Information The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2022 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The condensed financial statements include some amounts that are based on management's best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company's common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.
Risks and Uncertainties	Risks and Uncertainties The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period to comply with certain new or revised accounting standards that have different effective dates for public and private companies.
Going Concern	Going Concern The Company had cash of $ 2,199,678 As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern within one year after the date the financial statements are issued. Management has plans to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, such as the White Lion equity line of credit (refer to Note 8) and additional future financing agreements. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s current level of cash is not sufficient to execute the business plan. For the foreseeable future, the Company will incur significant operating expenses, capital expenditures and working capital funding that will deplete cash on hand by February 2024.
Cash	Cash The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had no The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of September 30, 2023, the Company had approximately $ 1.9 million 1.4 million
Software Development Costs	Software Development Costs The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. We determined that no such impairments were required during the three months and nine months ended September 30, 2023. Software development costs of $ 213,705 394,893 743,208 1,673,517 458,973 262,703 1,331,823 693,441
Revenue Recognition	Revenue Recognition Revenue will be measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and will be recognized based on consideration specified in a contract with a customer, and excludes any sales incentives and amounts collected on behalf of third parties. The Company will recognize revenue when a performance obligation is satisfied by transferring control over a service or product to a customer. The Company will report revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the condensed statements of operations. Collected taxes will be recorded within Other current liabilities until remitted to the relevant taxing authority. Subscriber revenue will consist primarily of subscription fees and other ancillary subscription-based revenues. Revenue will be recognized on a straight-line basis when the performance obligations to provide each service for the period are satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions. Customers may pay for the services in advance of the performance obligation and therefore these prepayments would be recorded as deferred revenue. The deferred revenue will be recognized as revenue in the statement of operations as the services are provided.
Share-Based Compensation	Share-Based Compensation The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant in accordance with ASC 718. Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods. Certain share-based compensation awards include a net-share settlement feature that provides the grantee an option to withhold shares to satisfy tax withholding requirements and are classified as a share-based compensation liability. Cash paid to satisfy tax withholdings is classified as financing activities in the condensed statements of cash flows.
Recently Adopted ASUs	Recently Adopted ASUs ASU 2016-13-Financial Instruments-Credit Losses-

Property & Equipment and Soft_2

Property & Equipment and Software Development Costs (Tables)	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of property, equipment and software development costs	Schedule of property, equipment and software development costs September 30, 2023 December 31, 2022 Computers and equipment $ 99,939 $ 99,939 Furniture 7,263 7,262 Accumulated depreciation (85,118 ) (66,121 ) Total property and equipment, net $ 22,084 $ 41,080 Software development costs $ 7,369,257 $ 6,626,049 Accumulated amortization (3,823,647 ) (2,491,824 ) Total software development costs, net $ 3,545,610 $ 4,134,225

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Schedule of accounts payable and accrued liabilities	Schedule of accounts payable and accrued liabilities September 30, 2023 December 31, 2022 Accounts payable and accrued liabilities $ 269,159 $ 289,955 Credit cards payable 14,517 6,072 Accrued interest 303,965 28,111 Total accounts payable and accrued liabilities $ 587,641 $ 324,138

Share-based Issuances (Tables)

Share-based Issuances (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Schedule of stock option activity	Schedule of stock option activity Options Weighted Average Exercise Price Outstanding - December 31, 2022 1,663,173 $ 2.45 Granted 200,200 0.94 Forfeited/canceled (206,454 ) 1.51 Exercised – – Outstanding - September 30, 2023 1,656,919 $ 2.38
Schedule of options outstanding and exercisable	Schedule of options outstanding and exercisable Options Outstanding Options Exercisable Exercise Prices Number Price Life* Number Price* $2.70 22,264 $ 2.70 0.75 22,264 $ 2.70 $2.90 53,128 $ 2.90 4.11 53,128 $ 2.90 $4.26 171,197 $ 4.26 5.73 171,197 $ 4.26 $2.79 772,194 $ 2.79 7.23 553,122 $ 2.79 $1.79 198,750 $ 1.79 7.87 68,437 $ 1.79 $1.21 389,386 $ 1.21 8.95 292,039 $ 1.21 $0.40 50,000 $ 0.40 9.69 – $ 0.40 Total - September 30, 2023 1,656,919 $ 2.38 1,160,187 $ 2.59 * Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.
Schedule of restricted stock units outstanding	Schedule of restricted stock units outstanding Restricted Stock Units Weighted Average Grant Date Fair Value Outstanding - December 31, 2022 563,859 $ 2.14 Granted 37,500 1.24 Forfeited/canceled (118,350 ) 1.83 Vested/issued (195,759 ) 1.83 Outstanding - September 30, 2023 287,250 $ 2.37
Schedule of warrant outstanding	Schedule of warrant outstanding Warrants Weighted Average Exercise Price Outstanding - December 31, 2022 4,472,099 $ 4.62 Granted 950,000 0.61 Forfeited/canceled – – Exercised – – Outstanding - September 30, 2023 5,422,099 $ 3.84

Description of Business, Basi_3

Description of Business, Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Accounting Policies [Abstract]
Cash	$ 2,199,678		$ 2,199,678		$ 1,661,434
Cash equivalents, at carrying value	0		0		0
Cash, uninsured amount	1,900,000		1,900,000		$ 1,400,000
Software development costs incurred	213,705	$ 394,893	743,208	$ 1,673,517
Amortization of software development costs	$ 458,973	$ 262,703	$ 1,331,823	$ 693,441

Property & Equipment and Soft_3

Property & Equipment and Software Development Costs (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Accumulated depreciation	$ (85,118)	$ (66,121)
Total property and equipment, net	22,084	41,080
Accumulated amortization	(3,823,647)	(2,491,824)
Total software development costs, net	3,545,610	4,134,225
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Computers and equipment, gross	99,939	99,939
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Furniture, gross	7,263	7,262
Software Development [Member]
Property, Plant and Equipment [Line Items]
Software, gross	$ 7,369,257	$ 6,626,049

Property & Equipment and Soft_4

Property & Equipment and Software Development Costs (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 6,193	$ 12,136	$ 18,997	$ 28,529
Equipment and amortization expense	$ 458,973	$ 262,703	$ 1,331,823	$ 693,441

Accounts payable and accrued _3

Accounts payable and accrued liabilities (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accounts payable and accrued liabilities	$ 269,159	$ 289,955
Credit cards payable	14,517	6,072
Accrued interest	303,965	28,111
Total accounts payable and accrued liabilities	$ 587,641	$ 324,138

Notes Payable to Related Part_2

Notes Payable to Related Party, net of debt issuance costs (Details Narrative) - Prior Note [Member] - USD ($)		1 Months Ended		3 Months Ended	9 Months Ended
	Nov. 30, 2022	May 31, 2023	Apr. 30, 2023	Sep. 30, 2023	Sep. 30, 2023
Debt Instrument [Line Items]
Debt face amount	$ 2,200,000
Original issue discount	$ 200,000
Warrants issued, shares	300,000
Warrants issued, value	$ 361,878
New Note [Member]
Debt Instrument [Line Items]
Debt face amount			$ 825,000
Original issue discount			$ 75,000
Warrants issued, shares			325,000
Debt face amount				$ 825,000	$ 825,000
Interest expense, debt				$ 401,441	$ 401,441
Additional Warrants [Member]
Debt Instrument [Line Items]
Warrants issued, shares			325,000
Warrants issued, value			$ 252,940
Additional Warrants [Member]
Debt Instrument [Line Items]
Warrants issued, shares		300,000
Warrants issued, value		$ 94,083
Original Issued Warrants [Member]
Debt Instrument [Line Items]
Warrants cancelled, shares			300,000
New Common Stock Warrants [Member]
Debt Instrument [Line Items]
Warrants issued, shares			600,000
Warrants issued, value			$ 35,981
Warrants vested		300,000	300,000
Warrants unvested			300,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 12,053	$ 39,935	$ 49,491	$ 83,117
Equity, Attributable to Parent	$ 2,415,012	$ 4,767,353	$ 2,415,012	$ 4,767,353	$ 4,331,777	$ 2,095,247	$ 3,850,083	$ 6,143,327	$ 7,915,053	$ 9,410,937

Share-based Issuances (Details

Share-based Issuances (Details - Option Activity) - Equity Option [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning | shares	1,663,173
Weighted average exercise price, beginning | $ / shares	$ 2.45
Options granted | shares	200,200
Weighted average exercise price, granted | $ / shares	$ 0.94
Options forfeited/cancelled | shares	(206,454)
Weighted average exercise price, forfeited/canceled | $ / shares	$ 1.51
Options exercised | shares	0
Weighted average exercise price, exercised | $ / shares	$ 0
Outstanding, ending | shares	1,656,919
Weighted average exercise price, ending | $ / shares	$ 2.38

Share-based Issuances (Detail_2

Share-based Issuances (Details - Options by Exercise Price) - Equity Option [Member] - $ / shares		9 Months Ended
		Sep. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		1,656,919	1,663,173
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 2.38	$ 2.45
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number		1,160,187
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	[1]	$ 2.59
Exercise Price 1 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		22,264
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 2.70
Weighted average contractual term	[1]	9 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number		22,264
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	[1]	$ 2.70
Exercise Price 2 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		53,128
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 2.90
Weighted average contractual term	[1]	4 years 1 month 9 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number		53,128
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	[1]	$ 2.90
Exercise Price 3 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		171,197
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 4.26
Weighted average contractual term	[1]	5 years 8 months 23 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number		171,197
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	[1]	$ 4.26
Exercise Price 4 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		772,194
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 2.79
Weighted average contractual term	[1]	7 years 2 months 23 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number		553,122
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	[1]	$ 2.79
Exercise Price 5 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		198,750
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 1.79
Weighted average contractual term	[1]	7 years 10 months 13 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number		68,437
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	[1]	$ 1.79
Exercise Price 6 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		389,386
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 1.21
Weighted average contractual term	[1]	8 years 11 months 12 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number		292,039
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	[1]	$ 1.21
Exercise Price 7 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		50,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price		$ 0.40
Weighted average contractual term	[1]	9 years 8 months 8 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number		0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	[1]	$ 0.40
[1] Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.

Share-based Issuances (Detail_3

Share-based Issuances (Details - Restricted Stock Units Activity) - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning | shares	563,859
Weighted average exercise price, beginning | $ / shares	$ 2.14
Restricted stock units granted | shares	37,500
Weighted average exercise price, granted | $ / shares	$ 1.24
Restricted stock units forfeited/cancelled | shares	(118,350)
Weighted average exercise price, forfeited/cancelled | $ / shares	$ 1.83
Restricted Stock Units vested issued | shares	(195,759)
Weighted average exercise price, vested issued | $ / shares	$ 1.83
Outstanding, ending | shares	287,250
Weighted average exercise price, ending | $ / shares	$ 2.37

Share-based Issuances (Detail_4

Share-based Issuances (Details - Warrant Activity) - Warrant [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding, beginning | shares	4,472,099
Weighted average exercise price, beginning | $ / shares	$ 4.62
Warrants granted | shares	950,000
Weighted average exercise price, granted | $ / shares	$ 0.61
Warrants Forfeited/cancelled | shares	0
Weighted average exercise price, granted | $ / shares	$ 0
Warrants Exercised | shares	0
Weighted average exercise price, granted | $ / shares	$ 0
Warrants outstanding, ending | shares	5,422,099
Weighted average exercise price, ending | $ / shares	$ 3.84

Share-based Issuances (Detail_5

Share-based Issuances (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation	$ 799,677	$ 698,486
Share-based compensation expense	$ 1,447,278
Equity Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units granted	200,200
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units granted	37,500
Fair value of vested shares over the service	$ 45,981
Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding	5,422,099		4,472,099
Warrants remaining contractual life	2 years 8 months 8 days

Net Loss Per Share (Details Nar

Net Loss Per Share (Details Narrative) - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net loss per share attributable to common stockholders
Dilutive weighted average shares	7,079,016	6,271,219

Equity Financings (Details Narr

Equity Financings (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended	9 Months Ended
	Jun. 30, 2023	Apr. 30, 2023	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Proceeds from sale of stock				$ 4,016,521	$ 0
S-3 Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued new, shares	4,735,000
Proceeds from sale of stock	$ 2,700,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued new, shares			7,096,514
White Lion Purchase Agreement [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued, shares	2,361,514	2,361,514
Number of shares issued value	$ 1,300,000	$ 1,300,000
Number of shares exceed				2,501,700